Released May 16, 2016, after the close
10-Q filed May 16, 2016, 46 days after period end · 0001171843-16-010082
Q1 2016 · 10-Q
Revenue$26.96M$26.96M +4.7% vs Q1 2015−5.0% vs Q4 2015
Net Income-$636.00K-$636.00K N/M vs Q1 2015N/M vs Q4 2015
EPS Diluted-$0.02-$0.02 N/M vs Q1 2015N/M vs Q4 2015
Gross Profit$12,945,000+12.8%
Operating Income-$221,000N/M
Operating Cash Flow-$726,000N/M
Margins · derived
Gross margin48.0%+3.5 pt vs Q1 2015
Operating margin-0.8%+3.6 pt vs Q1 2015
Net margin-2.4%+3.1 pt vs Q1 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | $26.96M | $25.76M | $25.89M | $26.09M |
| Net Income | -$636.00K | -$1.40M | $719.00K | $96.00K |
| EPS Diluted | -$0.02 | -$0.04 | $0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR